Haleon (MEX:HLN1) Pre-Tax Income : MXN45,803 Mil (TTM As of Dec. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Haleon Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Haleon's pretax income for the three months ended in Dec. 2024 was MXN7,593 Mil. Its pretax income for the trailing twelve months (TTM) ended in Dec. 2024 was MXN45,803 Mil. Haleon's pretax margin was 10.44%.

During the past 6 years, Haleon's highest Pretax Margin was 17.14%. The lowest was 10.45%. And the median was 15.49%.

Haleon Pre-Tax Income Historical Data

The historical data trend for Haleon's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Haleon Pre-Tax Income Chart

Haleon Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Pre-Tax Income

Get a 7-Day Free Trial

42,537.87

44,628.86

38,422.08

34,979.84

50,359.53

Haleon Quarterly Data
	Dec19	Dec20	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Pre-Tax Income	Get a 7-Day Free Trial											3,695.66	12,441.92	9,463.06	16,304.40	7,593.48

Competitive Comparison of Haleon's Pre-Tax Income

For the Drug Manufacturers - Specialty & Generic subindustry, Haleon's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Haleon's Pre-Tax Income Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Haleon's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Haleon's Pre-Tax Income falls into.

Save Embed

;

Save Embed

;

Haleon Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Haleon's Pretax Income for the fiscal year that ended in Dec. 2024 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	58163.937	+	0	+	-10388.301	+	1713.806	+	870.086
	=	50,360

Haleon's Pretax Income for the quarter that ended in Dec. 2024 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	9228.186	+	0	+	-2926.653	+	580.057	+	711.889
	=	7,593

Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN45,803 Mil.

Haleon (MEX:HLN1) Pre-Tax Income Explanation

Haleon's Pretax Margin for the quarter that ended in Dec. 2024 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	7593.479	/	72744.471
	=	10.44%

During the past 6 years, Haleon's highest Pretax Margin was 17.14%. The lowest was 10.45%. And the median was 15.49%.

Haleon Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Haleon's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Haleon Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Haleon PLC (MEX:HLN1) » Definitions » Pre-Tax Income

Comparable Companies

Traded in Other Exchanges

HLNCF:USA HLN:USA HLN:Mexico HLNl:UK HLN:UK H6D0:Germany

Address

The Heights, Building 5, First Floor, Surrey, Weybridge, GBR, KT13 0NY

Website

https://www.haleon.com

Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.

Haleon Headlines

No Headlines